Fig. 1
From: miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
MiR-133a can reduce cisplatin resistance in cisplatin-resistant ovarian cancer cell lines. A MiR-133a is downregulated in SKOV3-DDP and A2780-DDP cell lines compared with SKOV3 and A2780 cells, respectively. B MiR-133a knockdown induced cisplatin resistance in A2780 and SKOV3 cells. C MiR-133a mimic increased cisplatin sensitivity in A2780-DDP and SKOV3-DDP cell lines. For comparisons, Student’s t test was performed; *p < 0.05, **p < 0.01, ***p < 0.001